Acute interstitial nephritis secondary to vedolizumab.

Nicholas SimpsonJohn Paul SeenanRajan PatelDavid Kipgen

Published in: BMJ case reports (2021)

We present a patient with an acute kidney injury thought secondary to acute interstitial nephritis as a result of vedolizumab maintenance therapy for Crohn's disease. This appears to be a rare but serious side effect in patients receiving this treatment which clinicians should consider in the event of renal dysfunction.

Keyphrases

liver failure
acute kidney injury
respiratory failure
ulcerative colitis
drug induced
patients with inflammatory bowel disease
aortic dissection
cardiac surgery
oxidative stress
palliative care
intensive care unit
extracorporeal membrane oxygenation